According to the FDA, more than 30 million people in the US are affected by rare disease or 1 in 10. According to the CDC, coronary artery disease affects 1 in 20.
Elliott, E. Zurynski, Y. (2015). Rare diseases are a ‘common’ problem for clinicians. Australian Family Physician. 44. (9):630-3. PMID: 26488039. https://www.researchgate.net/publication/282949083_Rare_diseases_are_a_’common’_problem_for_clinicians
Chrivoli, J. A., & Lester, N. (2019). Common themes and characteristics of trauma in the healthcare experiences of patients with rare disease: A literature analysis https://doi.org/10.13140/RG.2.2.27558.47684
Shirvani, A., Shirvani, P., Jonah, U., Moore, B. E., & Holick, M. F. (2025). Suspected Mitochondrial Dysfunction and Complex Pathophysiology in Fatal Hypermobile Ehlers–Danlos Syndrome: Insights from a Case Report and Post-Mortem Findings. Biomedicines, 13(2), 469. https://doi.org/10.3390/biomedicines13020469
Shirvani P, Shirvani A, Holick MF. (2024). Decoding the Genetic Basis of Mast Cell Hypersensitivity and Infection Risk in Hypermobile Ehlers-Danlos Syndrome. Curr Issues Mol Biol.46(10):11613-11629. https://pubmed.ncbi.nlm.nih.gov/39451569/doi: 10.3390/cimb46100689. PMID: 39451569; PMCID: PMC11506785.
Mental Health and Well-being Resources for Healthcare Workers
Confidential and Professional Support